Department of Surgery, Faculty of Medical and Health Sciences (FMHS), University of Auckland, Private Bag 92-019, Auckland, 1023, New Zealand.
Department of Orthopaedic Surgery, North Shore Hospital, Private Bag 93-503, Auckland, 0620, New Zealand.
Knee Surg Sports Traumatol Arthrosc. 2023 Oct;31(10):4109-4116. doi: 10.1007/s00167-023-07503-y. Epub 2023 Jul 14.
Osteoarthritis (OA) is associated with inflammation, and residual inflammation may influence outcomes following knee arthroplasty. This may be more relevant for patients undergoing unicompartmental knee arthroplasty (UKA) due to larger remaining areas of native tissue. This study aimed to: (1) characterise inflammatory profiles for medial UKA patients and (2) investigate whether inflammation markers are associated with post-operative outcomes.
This prospective, observational study has national ethics approval. Bloods, synovial fluid, tibial plateaus and synovium were collected from medial UKA patients in between 1 January 2021 and 31 December 2021. Cytokine and chemokine concentrations in serum and synovial fluid (SF) were measured with multiplexed assays. Disease severity of cartilage and synovium was assessed using validated histological scores. Post-operative outcomes were measured with Oxford Knee Score (OKS), Forgotten Joint Score (FJS-12) and pain scores.
The study included 35 patients. SF VEGFA was negatively correlated with pre-operative pain at rest (r - 0.5, p = 0.007), and FJS-12 at six-week (r 0.44, p = 0.02), six-month (r 0.61, p < 0.01) and one-year follow-up (r 0.63, p = 0.03). Serum and SF IL-6 were positively correlated with OKS at early follow-up (serum 6 weeks, r 0.39, p = 0.03; 6 months, r 0.48, p < 0.01; SF 6 weeks, r 0.35, p = 0.04). At six weeks, increased synovitis was negatively correlated with improvements in pain at rest (r - 0.41, p = 0.03) and with mobilisation (r - 0.37, p = 0.047).
Lower levels of synovitis and higher levels of IL-6 and VEGFA were associated with better post-operative outcomes after UKA, which could be helpful for identifying UKA patients in clinical practice.
Level IV case series.
骨关节炎(OA)与炎症有关,残留的炎症可能会影响膝关节置换术后的结果。对于接受单髁膝关节置换术(UKA)的患者,由于剩余的原生组织面积较大,这种影响可能更为明显。本研究旨在:(1)描述内侧 UKA 患者的炎症特征;(2)探讨炎症标志物是否与术后结果相关。
本前瞻性观察性研究已获得国家伦理批准。在 2021 年 1 月 1 日至 12 月 31 日期间,从内侧 UKA 患者中采集血液、滑膜液、胫骨平台和滑膜。使用多重分析测定血清和滑膜液(SF)中的细胞因子和趋化因子浓度。使用经过验证的组织学评分评估软骨和滑膜的疾病严重程度。术后结果采用牛津膝关节评分(OKS)、遗忘关节评分(FJS-12)和疼痛评分进行评估。
该研究共纳入 35 例患者。SF 血管内皮生长因子 A(VEGFA)与术前静息时疼痛呈负相关(r=-0.5,p=0.007),与术后 6 周(r=0.44,p=0.02)、6 个月(r=0.61,p<0.01)和 1 年随访(r=0.63,p=0.03)时的 FJS-12 呈负相关。血清和 SF 白细胞介素 6(IL-6)与早期随访时的 OKS 呈正相关(血清:6 周,r=0.39,p=0.03;6 个月,r=0.48,p<0.01;SF:6 周,r=0.35,p=0.04)。6 周时,滑膜炎程度增加与静息时疼痛(r=-0.41,p=0.03)和活动时疼痛(r=-0.37,p=0.047)改善呈负相关。
UKA 术后滑膜炎症程度降低、IL-6 和 VEGFA 水平升高与术后结果改善相关,这有助于在临床实践中识别 UKA 患者。
IV 级病例系列研究。